US Patent 11332441 Crystalline N-methyl tryptamine derivatives
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113324410
Date of Patent
May 17, 2022
0Patent Application Number
168270720
Date Filed
March 23, 2020
0Patent Primary Examiner
CPC Code
Edits on 24 Mar, 2023
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113324410
Date of Patent
May 17, 2022
0Patent Application Number
168270720
Date Filed
March 23, 2020
0Patent Primary Examiner
CPC Code
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+446 characters)
US Patent 11332441 Crystalline N-methyl tryptamine derivatives
Article
Crystalline N-methyl tryptamine derivatives, compositions containing those crystalline forms and their methods of use are disclosed. The crystalline N-methyl tryptamine derivatives according to the invention include crystalline N-methyl-N-propyltryptamine (MPT), crystalline N-methyl-N-isopropyltryptammonium fumarate (MiPT fumarate) and crystalline 4-hydroxy-N-methyl-N-isopropyltryptammonium fumarate monohydrate (HO-MiPT fumarate monohydrate).
Infobox
Is a
Patent jurisdiction
Patent number
11332441
Date of patent
May 17, 2022
Patent application number
16827072
Date Filed
March 23, 2020
Patent primary examiner
CPC Code
Find more entities like US Patent 11332441 Crystalline N-methyl tryptamine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
